According to Pacific Biosciences 's latest financial reports the company's current earnings are NZ$0.17 Billion. In 2023 the company made an earning of -NZ$0.56 Billion a decrease over its 2022 earnings that were of -NZ$0.56 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -NZ$0.65 Billion | 15% |
2023 | -NZ$0.56 Billion | 1.24% |
2022 | -NZ$0.56 Billion | 14.33% |
2021 | -NZ$0.49 Billion | -1034.84% |
2020 | NZ$51.59 M | -134.95% |
2019 | -NZ$0.15 Billion | -17.97% |
2018 | -NZ$0.18 Billion | 11.25% |
2017 | -NZ$0.17 Billion | 23.95% |
2016 | -NZ$0.14 Billion | 134.65% |
2015 | -NZ$55.62 Million | -52.09% |
2014 | -NZ$0.12 Billion | -16.56% |
2013 | -NZ$0.14 Billion | -16.08% |
2012 | -NZ$0.17 Billion | -13.78% |
2011 | -NZ$0.2 Billion | -21.76% |
2010 | -NZ$0.25 Billion |